|
[671] Feldman, David, 2002. Pathways of Vitamin D Action to Inhibit Prostate Cancer Cell Growth, www.annieappleseedproject.org/nutgenprotin.html [672] Campbell, T.C, and Campbell, T.M., 2006. The China Study . Benbella Books. [673] http://bioscience.igh.cnrs.fr/2001/v6/d/hansen/2.asp [674] Seol, J.G. and fi ve others, 1998. Telomerase activity in acme myelogenous leukemia: clinical and biological implications. Br. J. Haematology , 100, 156–165; Savoysky, E. and seven others, 1996, Down-regulation of telomerase activity is an early event in the differentiation in HL-60 cells. Biochem. Biophys. Res. Commun. , 226, 329–334; Albanell, J. and fi ve others, 1996. Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines. Cancer Res. , 56, 1503–1508. [675] Campbell. T. Colin, Campbell, Thomas M. II, Robbins, John and Lyman Howard, 2006. The China Study: The Most Comprehensive Study of Nutrition Ever Conducted and the Startling Implications for Diet, Weight Loss and Long-term Health, Benbella Books. [676] Barretto, A.M., Schwartz, G.G., Woofruff, R. and Cramer, S.C., 2000. 5-hydroxyvitamin D-3, the prohormone of 1,25-dihydroxyvitamin D-3, inhibits the proliferation of primary prostatic epithelial cells. Cancer Epidemiology Biomarkers & Prevention , 9, 3, 265–270. [677] http://www.rense.com/gencral/dair.htm [678] Spallholz, J.E., Stewart, J.R., 1989. Advances in the role of minerals in immunobiology. Center for Food and Nutrition, Texas Tech University, Lubbock 79409. Biol Trace Elem Res. Mar , 19 (3) 129–151. [679] Gynecologic , 2004, 93, 320–327. [680] Redbook, April, 1989, v172, n6, p. 96 (5). [681] Niki, E., Noguchi, N, Tsuchihashi, H. and others, 1995. Interaction among vitamin C, vitamin E and beta-carotene. Am. J. Clin. Nutr., 62 (Suppl), 1322S-1326S. [682] Craig, Winston J., 2002. Phyiochemicals: Guardians of Our Health, http://www.andrews.edu/NUFS/phyto.html, 03/12/02. [683] New Scientist , August 2006. [684] Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя. [685] Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя. [686] Следуйте инструкциям изготовителя и не превышайте рекомендуемую дозу. Качество таблеток или жиров зависит от фирмы-производителя. — 383 —
|